Modulatory roles of glycolytic enzymes in cell death

Biochemical Pharmacology

Volumn 92, Issue 1, 2014, Pages 22-30

  Cerella, Claudia ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Cancer; Cell death; GAPDH; Glycolysis; Hexokinase

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOLYTIC ENZYME; HEXOKINASE;

APOPTOSIS; CANCER THERAPY; CELL DEATH; CELL METABOLISM; ENZYME METABOLISM; ENZYME STRUCTURE; GLYCOLYSIS; HUMAN; METABOLIC REGULATION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; ENERGY METABOLISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASMS; PHYSIOLOGY;

CELL DEATH; ENERGY METABOLISM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GLYCOLYSIS; HEXOKINASE; HUMANS; NEOPLASMS;

EID: 84908317046     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.07.005     Document Type: Review

References (112)

1. P.S. Ward, and C.B. Thompson Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate Cancer Cell 21 2012 297 308
2. C. Cerella, A. Gaigneaux, M. Dicato, and M. Diederich Antagonistic role of natural compounds in mTOR-mediated metabolic reprogramming Cancer Lett 2014
3. A. Colell, J.E. Ricci, S. Tait, S. Milasta, U. Maurer, and L. Bouchier-Hayes GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation Cell 129 2007 983 997
4. C. Cerella, F. Radogna, M. Dicato, and M. Diederich Natural compounds as regulators of the cancer cell metabolism Int J Cell Biol 2013 2013 639401
5. M.A. Sirover Subcellular dynamics of multifunctional protein regulation: mechanisms of GAPDH intracellular translocation J Cell Biochem 113 2012 2193 2200
6. C. Tristan, N. Shahani, T.W. Sedlak, and A. Sawa The diverse functions of GAPDH: views from different subcellular compartments Cell Signal 23 2011 317 323
7. D.S. Ucker, M.R. Jain, G. Pattabiraman, K. Palasiewicz, R.B. Birge, and H. Li Externalized glycolytic enzymes are novel, conserved, and early biomarkers of apoptosis J Biol Chem 287 2012 10325 10343
8. C. Cerella, M.H. Teiten, F. Radogna, M. Dicato, and M. Diederich From nature to bedside: pro-survival and cell death mechanisms as therapeutic targets in cancer treatment Biotechnol Adv 2014
9. S. Coppola, and L.G.S.H. Ghibelli extrusion and the mitochondrial pathway of apoptotic signalling Biochem Soc Trans 28 2000 56 61
10. L. Galluzzi, I. Vitale, J.M. Abrams, E.S. Alnemri, E.H. Baehrecke, and M.V. Blagosklonny Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 Cell Death Differ 19 2012 107 120
11. H. Li, H. Zhu, C.J. Xu, and J. Yuan Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 94 1998 491 501
12. K.S. Ferreira, C. Kreutz, S. Macnelly, K. Neubert, A. Haber, and M. Bogyo Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas signaling in primary mouse hepatocytes Apoptosis 17 2012 503 515
13. J. Han, C.Q. Zhong, and D.W. Zhang Programmed necrosis: backup to and competitor with apoptosis in the immune system Nat Immunol 12 2011 1143 1149
14. A. Kaczmarek, P. Vandenabeele, and D.V. Krysko Necroptosis: the release of damage-associated molecular patterns and its physiological relevance Immunity 38 2013 209 223
15. S.W. Tait, and D.R. Green Caspase-independent cell death: leaving the set without the final cut Oncogene 27 2008 6452 6461
16. T. Vanden Berghe, A. Linkermann, S. Jouan-Lanhouet, H. Walczak, and P. Vandenabeele Regulated necrosis: the expanding network of non-apoptotic cell death pathways Nat Rev Mol Cell Biol 15 2014 135 147
17. W. Declercq, T. Vanden Berghe, and P. Vandenabeele RIP kinases at the crossroads of cell death and survival Cell 138 2009 229 232
18. A. Degterev, J. Hitomi, M. Germscheid, I.L. Ch'en, O. Korkina, and X. Teng Identification of RIP1 kinase as a specific cellular target of necrostatins Nat Chem Biol 4 2008 313 321
19. L. Wang, F. Du, and X. Wang TNF-alpha induces two distinct caspase-8 activation pathways Cell 133 2008 693 703
20. T. Tenev, K. Bianchi, M. Darding, M. Broemer, C. Langlais, and F. Wallberg The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs Mol Cell 43 2011 432 448
21. W. Han, L. Li, S. Qiu, Q. Lu, Q. Pan, and Y. Gu Shikonin circumvents cancer drug resistance by induction of a necroptotic death Mol Cancer Ther 6 2007 1641 1649
22. S.W. Ryter, K. Mizumura, and A.M. Choi The impact of autophagy on cell death modalities Int J Cell Biol 2014 2014 502676
23. S. Mukhopadhyay, P.K. Panda, N. Sinha, D.N. Das, and S.K. Bhutia Autophagy and apoptosis: where do they meet Apoptosis 19 2014 555 566
24. D.J. Klionsky, F.C. Abdalla, H. Abeliovich, R.T. Abraham, A. Acevedo-Arozena, and K. Adeli Guidelines for the use and interpretation of assays for monitoring autophagy Autophagy 8 2012 445 544
25. M.P. Tschan, and H.U. Simon The role of autophagy in anticancer therapy: promises and uncertainties J Int Med 268 2010 410 418
26. C. Cerella, C. Michiels, R.H. Dashwood, Y.J. Surh, and M. Diederich Metabolism and cancer: old and new players Int J Cell Biol 2013 2013 293201
27. A. Colell, D.R. Green, and J.E. Ricci Novel roles for GAPDH in cell death and carcinogenesis Cell Death Differ 16 2009 1573 1581
28. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria Oncogene 25 2006 4777 4786
29. K.K. Arora, C.R. Filburn, and P.L. Pedersen Structure/function relationships in hexokinase. Site-directed mutational analyses and characterization of overexpressed fragments implicate different functions for the N- and C-terminal halves of the enzyme J Biol Chem 268 1993 18259 18266
30. 2- and COOH-terminal halves J Biol Chem 271 1996 1849 1852
31. H.J. Tsai, and J.E. Wilson Functional organization of mammalian hexokinases: both N- and C-terminal halves of the rat type II isozyme possess catalytic sites Arch Biochem Biophys 329 1996 17 23
32. D. Sui, and J.E. Wilson Structural determinants for the intracellular localization of the isozymes of mammalian hexokinase: intracellular localization of fusion constructs incorporating structural elements from the hexokinase isozymes and the green fluorescent protein Arch Biochem Biophys 345 1997 111 125
33. J.G. Pastorino, N. Shulga, and J.B. Hoek Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis J Biol Chem 277 2002 7610 7618
34. J.G. Pastorino, and J.B. Hoek Regulation of hexokinase binding to VDAC J Bioenerg Biomembr 40 2008 171 182
35. J. Penso, and R. Beitner Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells Eur J Pharmacol 342 1998 113 117
36. N. Majewski, V. Nogueira, P. Bhaskar, P.E. Coy, J.E. Skeen, and K. Gottlob Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak Mol Cell 16 2004 819 830
37. S. Abu-Hamad, H. Zaid, A. Israelson, E. Nahon, and V. Shoshan-Barmatz Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding J Biol Chem 283 2008 13482 13490
38. C.M. Furtado, M.C. Marcondes, M. Sola-Penna, M.L. de Souza, and P. Zancan Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis PLoS One 7 2012 e30462
39. L. Ghibelli, and M. Diederich Multistep and multitask Bax activation Mitochondrion 10 2010 604 613
40. K. Machida, Y. Ohta, and H. Osada Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells J Biol Chem 281 2006 14314 14320
41. N. Harada, R. Yasunaga, Y. Higashimura, R. Yamaji, K. Fujimoto, and J. Moss Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells J Biol Chem 282 2007 22651 22661
42. M. Backlund, K. Paukku, L. Daviet, R.A. De Boer, E. Valo, and S. Hautaniemi Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase Nucleic Acids Res 37 2009 2346 2358
43. N. Bonafe, M. Gilmore-Hebert, N.L. Folk, M. Azodi, Y. Zhou, and S.K. Chambers Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3′ untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype Cancer Res 65 2005 3762 3771
44. E.J. Tisdale, C. Kelly, and C.R. Artalejo Glyceraldehyde-3-phosphate dehydrogenase interacts with Rab2 and plays an essential role in endoplasmic reticulum to Golgi transport exclusive of its glycolytic activity J Biol Chem 279 2004 54046 54052
45. P.E. Glaser, X. Han, and R.W. Gross Tubulin is the endogenous inhibitor of the glyceraldehyde 3-phosphate dehydrogenase isoform that catalyzes membrane fusion: Implications for the coordinated regulation of glycolysis and membrane fusion Proc Nat Acad Sci USA 99 2002 14104 14109
46. S. Azam, N. Jouvet, A. Jilani, R. Vongsamphanh, X. Yang, and S. Yang Human glyceraldehyde-3-phosphate dehydrogenase plays a direct role in reactivating oxidized forms of the DNA repair enzyme APE1 J Biol Chem 283 2008 30632 30641
47. C. Durrieu, F. Bernier-Valentin, and B. Rousset Binding of glyceraldehyde 3-phosphate dehydrogenase to microtubules Mol Cell Biochem 74 1987 55 65
48. M.R. Hara, and S.H. Snyder Nitric oxide-GAPDH-Siah: a novel cell death cascade Cell Mol Neurobiol 26 2006 527 538
49. H. Nakajima, W. Amano, A. Fujita, A. Fukuhara, Y.T. Azuma, and F. Hata The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death J Biol Chem 282 2007 26562 26574
50. F. Rodriguez-Pascual, M. Redondo-Horcajo, N. Magan-Marchal, D. Lagares, A. Martinez-Ruiz, and H. Kleinert Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability Mol Cell Biol 28 2008 7139 7155
51. A.E. Brodie, and D.J. Reed Reversible oxidation of glyceraldehyde 3-phosphate dehydrogenase thiols in human lung carcinoma cells by hydrogen peroxide Biochem Biophys Res Commun 148 1987 120 125
52. M.R. Hara, M.B. Cascio, and A. Sawa GAPDH as a sensor of NO stress Biochim Biophys Acta 1762 2006 502 509
53. C. Batthyany, F.J. Schopfer, P.R. Baker, R. Duran, L.M. Baker, and Y. Huang Reversible post-translational modification of proteins by nitrated fatty acids in vivo J Biol Chem 281 2006 20450 20463
54. N.R. Hwang, S.H. Yim, Y.M. Kim, J. Jeong, E.J. Song, and Y. Lee Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions Biochem J 423 2009 253 264
55. F. Revillion, V. Pawlowski, L. Hornez, and J.P. Peyrat Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer Eur J Cancer 36 2000 1038 1042
56. R.H. Rondinelli, D.E. Epner, and J.V. Tricoli Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer Prostate Cancer Prostatic Dis 1 1997 66 72
57. N. Schek, B.L. Hall, and O.J. Finn Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma Cancer Res 48 1988 6354 6359
58. K. Tokunaga, Y. Nakamura, K. Sakata, K. Fujimori, M. Ohkubo, and K. Sawada Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers Cancer Res 47 1987 5616 5619
59. R. Puzone, G. Savarino, S. Salvi, M.G. Dal Bello, G. Barletta, and C. Genova Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients Mol Cancer 12 2013 97
60. E. Ferraro, A. Pulicati, M.T. Cencioni, M. Cozzolino, F. Navoni, and S. di Martino Apoptosome-deficient cells lose cytochrome c through proteasomal degradation but survive by autophagy-dependent glycolysis Mol Biol Cell 19 2008 3576 3588
61. S.W. Tait, M.J. Parsons, F. Llambi, L. Bouchier-Hayes, S. Connell, and C. Munoz-Pinedo Resistance to caspase-independent cell death requires persistence of intact mitochondria Dev Cell 18 2010 802 813
62. M.A. Jacquin, J. Chiche, B. Zunino, M. Beneteau, O. Meynet, and L.A. Pradelli GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death Cell Death Differ 20 2013 1043 1054
63. 2-induced block of glycolysis as an active ADP-ribosylation reaction protecting cells from apoptosis FASEB J 14 2000 2266 2276
64. 2+ alterations in pre-apoptotic cells Apoptosis 12 2007 2207 2219
65. C. Cerella, M. D'Alessio, S. Cristofanon, M. De Nicola, F. Radogna, and M. Dicato Subapoptogenic oxidative stress strongly increases the activity of the glycolytic key enzyme glyceraldehyde 3-phosphate dehydrogenase Ann NY Acad Sci 1171 2009 583 590
66. M. D'Alessio, C. Cerella, C. Amici, C. Pesce, S. Coppola, and C. Fanelli Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells FASEB J 18 2004 1609 1611
67. S. Cristofanon, F. Morceau, A.I. Scovassi, M. Dicato, L. Ghibelli, and M. Diederich Oxidative, multistep activation of the noncanonical NF-kappaB pathway via disulfide Bcl-3/p50 complex FASEB J 23 2009 45 57
68. C. Cerella, M. Diederich, and L. Ghibelli The dual role of calcium as messenger and stressor in cell damage, death, and survival Int J Cell Biol 2010 2010 546163
69. N. Wong, J. De Melo, and D. Tang PKM2, a central point of regulation in cancer metabolism Int J Cell Biol 2013 2013 242513
70. M.B. Boxer, J.K. Jiang, M.G. Vander Heiden, M. Shen, A.P. Skoumbourdis, and N. Southall Evaluation of substituted N,N′-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase J Med Chem 53 2010 1048 1055
71. O.H. Kwon, T.W. Kang, J.H. Kim, M. Kim, S.M. Noh, and K.S. Song Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level Biochem Biophys Res Commun 423 2012 38 44
72. W. Luo, H. Hu, R. Chang, J. Zhong, M. Knabel, and R. O'Meally Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 Cell 145 2011 732 744
73. Z. Zhou, Y. Liu, M. Qin, W. Sheng, X. Wang, and Z. Li Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells J Photochem Photobiol, B: Chem 134 2014 1 8
74. P. Yang, Z. Li, R. Fu, H. Wu, and Z. Li Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling Cell Signal 2014
75. X. Gao, H. Wang, J.J. Yang, X. Liu, and Z.R. Liu Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase Mol Cell 45 2012 598 609
76. A. Stetak, R. Veress, J. Ovadi, P. Csermely, G. Keri, and A. Ullrich Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death Cancer Res 67 2007 1602 1608
77. M. Morfouace, L. Lalier, L. Oliver, M. Cheray, C. Pecqueur, and P.F. Cartron Control of glioma cell death and differentiation by PKM2-Oct4 interaction Cell Death Dis 5 2014 e1036
78. J. Han, Y. Miyamae, H. Shigemori, and H. Isoda Neuroprotective effect of 3,5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1 Neuroscience 169 2010 1039 1045
79. C. Mazzoni, M. Torella, A. Petrera, V. Palermo, and C. Falcone PGK1, the gene encoding the glycolitic enzyme phosphoglycerate kinase, acts as a multicopy suppressor of apoptotic phenotypes in S. cerevisiae Yeast 26 2009 31 37
80. C. Lepleux, E. Abeilard-Lemoisson, M. Duval, P. Icard, and H. Lincet siPGK1 sensitizes chemoresistant human ovarian cancer cell lines to cisplatin Anticancer Res 32 2012 4277 4286
81. J. Lu, T. Suzuki, M. Satoh, S. Chen, T. Tomonaga, and F. Nomura Involvement of aldolase A in X-ray resistance of human HeLa and UV(r)-1 cells Biochem Biophys Res Commun 369 2008 948 952
82. J.E. Slemmer, E.D. Haasdijk, D.C. Engel, N. Plesnila, and J.T. Weber Aldolase C-positive cerebellar Purkinje cells are resistant to delayed death after cerebral trauma and AMPA-mediated excitotoxicity Eur J Neurosci 26 2007 649 656
83. J.H. Chuang, M.H. Chou, M.H. Tai, T.K. Lin, C.W. Liou, and T. Chen 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth Int J Biochem Cell Biol 45 2013 944 951
84. S. Gupta, R. Mathur, and B.S. Dwarakanath The glycolytic inhibitor 2-deoxy-d-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice Cancer Biol Ther 4 2005 87 94
85. G. Maschek, N. Savaraj, W. Priebe, P. Braunschweiger, K. Hamilton, and G.F. Tidmarsh 2-Deoxy-d-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo Cancer Res 64 2004 31 34
86. R.K. Minor, D.L. Smith Jr., A.M. Sossong, S. Kaushik, S. Poosala, and E.L. Spangler Chronic ingestion of 2-deoxy-d-glucose induces cardiac vacuolization and increases mortality in rats Toxicol Appl Pharmacol 243 2010 332 339
87. R. Angioli, M. Janicek, B. Sevin, R. Estape, H. Averette, and O. Koechli Use of lonidamine to potentiate the effect of cisplatin and carboplatin on platinum resistant human ovarian cancer cells Int J Oncol 11 1997 777 780
88. A. Biroccio, D. Del Bufalo, M. Fanciulli, T. Bruno, G. Zupi, and A. Floridi bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells Int J Cancer 82 1999 125 130
89. G. Robustelli della Cuna, and P. Pedrazzoli Toxicity and clinical tolerance of lonidamine Semin Oncol 18 1991 18 22
90. L. Milane, Z. Duan, and M. Amiji Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer PLoS One 6 2011 e24075
91. N. Li, C.X. Zhang, X.X. Wang, L. Zhang, X. Ma, and J. Zhou Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways Biomaterials 34 2013 3366 3380
92. S. Cardaci, E. Desideri, and M.R. Ciriolo Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug J Bioenerg Biomembr 44 2012 17 29
93. M.L. Fonda Bromopyruvate inactivation of glutamate apodecarboxylase. Kinetics and specificity Journal Biol Chem 251 1976 229 235
94. Z. Chen, H. Zhang, W. Lu, and P. Huang Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate Biochim Biophys Acta 1787 2009 553 560
95. S. Ganapathy-Kanniappan, J.F. Geschwind, R. Kunjithapatham, M. Buijs, J.A. Vossen, and I. Tchernyshyov Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death Anticancer Res 29 2009 4909 4918
96. Z. Tang, S. Yuan, Y. Hu, H. Zhang, W. Wu, and Z. Zeng Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-bromopyruvate propyl ester J Bioenerg Biomembr 44 2012 117 125
97. N.G. Schaefer, J.F. Geschwind, J. Engles, J.W. Buchanan, and R.L. Wahl Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma Transl Res 159 2012 51 57
98. S. Ota, J.F. Geschwind, M. Buijs, J.W. Wijlemans, B.K. Kwak, and S. Ganapathy-Kanniappan Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer Target Oncol 8 2013 145 151
99. S. Ganapathy-Kanniappan, R. Kunjithapatham, and J.F. Geschwind Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting Anticancer Res 33 2013 13 20
100. S.M. El Sayed, W.G. Mohamed, M.A. Seddik, A.S. Ahmed, A.G. Mahmoud, and W.H. Amer Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study Chin J Cancer 2014
101. K. Sakai, K. Hasumi, and A. Endo Identification of koningic acid (heptelidic acid)-modified site in rabbit muscle glyceraldehyde-3-phosphate dehydrogenase Biochim Biophys Acta 1077 1991 192 196
102. J.H. Kim, S. Lee, J.B. Park, S.D. Lee, J.H. Kim, and S.H. Ha Hydrogen peroxide induces association between glyceraldehyde 3-phosphate dehydrogenase and phospholipase D2 to facilitate phospholipase D2 activation in PC12 cells J Neurochem 85 2003 1228 1236
103. S. Kumagai, R. Narasaki, and K. Hasumi Glucose-dependent active ATP depletion by koningic acid kills high-glycolytic cells Biochem Biophys Res Commun 365 2008 362 368
104. L. Galluzzi, O. Kepp, N. Tajeddine, and G. Kroemer Disruption of the hexokinase-VDAC complex for tumor therapy Oncogene 27 2008 4633 4635
105. S. Klippel, J. Jakubikova, J. Delmore, M. Ooi, D. McMillin, and E. Kastritis Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells Br J Haematol 159 2012 340 351
106. D. Reischer, A. Heyfets, S. Shimony, J. Nordenberg, Y. Kashman, and E. Flescher Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma Br J Pharmacol 150 2007 738 749
107. H. Tsumura, M. Akimoto, H. Kiyota, Y. Ishii, H. Ishikura, and Y. Honma Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture Leukemia 23 2009 753 760
108. U. Elia, and E. Flescher PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells Neoplasia 10 2008 1303 1313
109. L. Wei, Y. Zhou, Q. Dai, C. Qiao, L. Zhao, and H. Hui Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma Cell Death Dis 4 2013 e601
110. R. Kachadourian, H.M. Brechbuhl, L. Ruiz-Azuara, I. Gracia-Mora, and B.J. Day Casiopeina IIgly-induced oxidative stress and mitochondrial dysfunction in human lung cancer A549 and H157 cells Toxicology 268 2010 176 183
111. F. Carvallo-Chaigneau, C. Trejo-Solis, C. Gomez-Ruiz, E. Rodriguez-Aguilera, L. Macias-Rosales, and E. Cortes-Barberena Casiopeina III-ia induces apoptosis in HCT-15 cells in vitro through caspase-dependent mechanisms and has antitumor effect in vivo Biometals 21 2008 17 28
112. J.E. Kim, B.C. Ahn, M.H. Hwang, Y.H. Jeon, S.Y. Jeong, and S.W. Lee Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma J Nucl Med 52 2011 1756 1763